Gaviscon and Thalidomide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Thalidomide (thalidomide). Common drug interactions include basal cell carcinoma among females and arterial thrombosis among males.
The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Thalidomide. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Gaviscon?
Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.
What is Thalidomide?
Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.
27 people who take Gaviscon and Thalidomide together, and have interactions are studied.

What are the common drug interactions of Gaviscon and Thalidomide, by gender? *:
female:
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Chronic myelomonocytic leukaemia (cancers of the blood-forming cells of the bone marrow)
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Dyspnoea exertional (breathlessness or shortness of breath)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
- Anaemia (lack of blood)
- Anxiety
male:
- Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
- Arthralgia (joint pain)
- Fatigue (feeling of tiredness)
- Pain
- Weight decreased
- Back pain
- Delirium (wild excitement)
- Hyperthermia (body temperature greatly above normal)
- Lung infection
- Necrosis (the death of body tissue)
What are the common drug interactions of Gaviscon and Thalidomide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chest pain
50-59:
- Blood creatinine increased
- Coma (state of unconsciousness lasting more than six hours)
- Epistaxis (bleed from the nose)
- Fluid overload (too much fluid in the blood)
- Hepatic failure (liver failure)
- Hyperpyrexia (extremely high fever)
- Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
- Multi-organ failure (multisystem organ failure)
- Muscle twitching
60+:
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hyperthermia (body temperature greatly above normal)
- Lung infection
- Necrosis (the death of body tissue)
- Neuralgia (pain in one or more nerves)
- Pain
- Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 22 people, 81.48%
- High Blood Pressure: 8 people, 29.63%
- Constipation: 7 people, 25.93%
- Chronic Thyroiditis (long lasting inflammation of thyroid gland): 5 people, 18.52%
- Bone Pain: 5 people, 18.52%
- Sodium Retention: 2 people, 7.41%
- Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 7.41%
- Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 7.41%
- Oedema Peripheral (superficial swelling): 2 people, 7.41%
- Infection: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Gaviscon and Thalidomide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gaviscon (12,355 reports)
- Thalidomide (16,473 reports)
Browse all drug interactions of Gaviscon and Thalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gaviscon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Thalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gaviscon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Thalidomide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate and thalidomide (the active ingredients of Gaviscon and Thalidomide, respectively), and Gaviscon and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Hydrochlorothiazide and Tapentadol Hydrochloride - a second ago
- Differin vs. Amnesteem, side effect and effectiveness comparison - 16 seconds ago
- Cough and Ocular Hyperaemia - 27 seconds ago
- Drug interactions of Amlodipine and Zide - 33 seconds ago
- Fever and drugs of ingredients of topiramate - 34 seconds ago
- Drug interactions of Synthroid and Orencia - 35 seconds ago
- Drug interactions of Ciprofloxacin and Tresiba - 40 seconds ago
- Acute Prerenal Failure and drugs of ingredients of pantoprazole sodium - 46 seconds ago
- Drug interactions of Inderal and Univasc - 47 seconds ago
- Drug interactions of Byetta and Mupirocin - 48 seconds ago